Akebia Therapeutics, Inc. (AKBA) vs Vogenx Inc. (VOGX)

A side-by-side comparison of Akebia Therapeutics, Inc. and Vogenx Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AKBA

Akebia Therapeutics, Inc.

$236M

$0.88HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

VOGX

Vogenx Inc.

$228M

$16.39HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — AKBA vs VOGX

growth of $100 · dividends reinvested · last 1y

AKBA +5.1% (+5.1%/yr)VOGX +31.9% (+31.9%/yr)VOGX compounded faster over this window

AKBA VOGX

Metrics side by side

Total return (annualized)

Metric	AKBA	VOGX
Total return (1Y)	-67.65%	N/A
Total return CAGR (3Y)	-4.03%	N/A
Total return CAGR (5Y)	-20.07%	N/A
Total return CAGR (10Y)	-20.53%	N/A

VOGX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full AKBA analysis Full VOGX analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.